MRD-POSITIVE
Clinical trials for MRD-POSITIVE explained in plain language.
Never miss a new study
Get alerted when new MRD-POSITIVE trials appear
Sign up with your email to follow new studies for MRD-POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for leukemia patients: drug targets hidden cancer cells after transplant
Disease control Recruiting nowThis study tests a drug called inotuzumab ozogamicin in people with acute lymphoblastic leukemia (ALL) who still have tiny amounts of cancer cells (called minimal residual disease, or MRD) after a stem cell transplant. The goal is to see if the drug can clear these remaining cell…
Matched conditions: MRD-POSITIVE
Phase: PHASE2 • Sponsor: Sheng-Li Xue, MD • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
CAR-T showdown: new trial pits High-Tech cell therapy against standard care to stop Leukemia's return
Disease control Recruiting nowThis study is testing whether a personalized cell therapy (CAR-T) is better than standard chemotherapy at clearing tiny amounts of leftover leukemia cells in patients who have already had a stem cell transplant. The goal is to prevent the cancer from coming back. About 70 patient…
Matched conditions: MRD-POSITIVE
Phase: PHASE3 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC